- Our LinkedIn Page
- Our Twitter Feed
- Our Facebook Page
- Newsletter Subscribe to our e-newsletter. Current Issue
- Our Flickr Feed
- Our YouTube Feed
Tags
Food BIO International Convention biotech industry Benefits of biotech crops One-on-One's Biofuel Technology Plant biotechnology biofuels global food crisis agriculture Industry Analysis climate change Partnering biotechnology patent Biotechnology Industry Health Care Sustainability Technology Transfer biofuelAuthors
- Abigail Hirsch
- Alan Eisenberg
- BIOtechNOW Editor
- Bruce Dale
- Celia Economides
- Colleen Lerro
- David Thomas, CFA
- George Goodno
- George MacDougall
- Jason Corum
- Jeff Joseph
- Jim Greenwood
- Karen Batra
- Kelly Cappio
- Lila Feisee
- Matt Carr
- Nathan Schock
- Paul Winters
- Paulina Ibarra
- Robbi Lycett
- Roy Zwahlen
- Sarah Sneeringer
- Sondra Behan
- Stephanie Fischer
- Stephen Marmaras
- Tracy Cooley
Author Archive: BIOtechNOW Editor
Confessions of a Cancer-Free Cancer Patient
By Sandra Dennis, Deputy General Counsel for Healthcare, the Biotechnology Industry Organization October is breast cancer awareness month. As a dear friend said to me recently — it’s a whole month? She also despises the whole pink ribbon thing. I didn’t dare mention to her that there’s a breast cancer stamp. While it could suggest a lack of empathy, she was treated for breast cancer several years ago, so she speaks from the perspective of Read More >
Bioterrorism: Ten Years Later
By Bob Graham, Jim Talent, Randy Larsen & Lynne Kidder of The WMD Center Ten years ago this week, while still in shock from the unspeakable horrors of 9/11, Americans were learning of a new threat—bioterrorism. As it turns out, the anthrax letters of October 2001 were a relatively small incident, in which 22 were infected and five died. Other than the psychological aspects and the costs of cleanup (in excess of $500 million), the Read More >
Biotechnology Delivers Medical Discoveries to Benefit Women Facing Breast Cancer
By Marc S. Hurlbert, Ph.D., Executive Director, Avon Foundation Breast Cancer Crusade The field of breast cancer has witnessed remarkable progress due to dedicated biotechnology and academic scientists, advocates, patients, nurses and physicians. Sixty years ago, a woman diagnosed with early stage breast cancer had less than a 55 percent chance of living 10 years, while today those odds are greater than 85 percent. We have made great advances in detecting cancer early with imaging including Read More >
Moving Beyond the Stem Cell Stalemate
By Michael J. Werner, Alliance for Regenerative Medicine For the past several years, attendees at the World Stem Cell Summit have focused their energies primarily on legislative and legal efforts to protect human embryonic stem cell research. When folks gather at this year’s meeting, they will once again confront the reality that research opponents will continue to try to block these efforts. James Sherley has filed an appeal to the US Court of Appeals, DC Circuit Read More >
Is Animal Biotechnology Progressing?
By David Edwards, PhD Director, Animal Biotechnology, BIO One year ago, I was pleased to testify before the U.S. Food and Drug Administration’s (FDA) Veterinary Medicine Advisory Committee (VMAC). The FDA convened its VMAC meetings on September 19-21, 2010 to discuss an application for a genetically engineered (GE) salmon. Developed by Massachusetts-based AquaBounty Technologies, a BIO member, the AquAdvantage salmon has been genetically engineered to grow year-round. Conventional salmon only grow in warmer months. This Read More >
